84
Participants
Start Date
May 28, 2025
Primary Completion Date
January 31, 2026
Study Completion Date
January 31, 2027
combination of diosmin, hesperidin, bromelain, and Ruscus aculeatus (Vesvein Gambe)
Although there is extensive clinical and pharmacological evidence regarding the activity of the individual components of the product, the specific effect of the fixed combination of diosmin, hesperidin, bromelain, and Ruscus aculeatus as a single entity on quality of life in subjects with symptoms compatible with the early stages of Chronic Venous Disease (CVD) has not yet been explored.
NOT_YET_RECRUITING
Azienda ULSS7 Pademontana Regione Veneto, Bassano del Grappa
NOT_YET_RECRUITING
AOU Policlinico Sant'Orsola Malpighi, Bologna
NOT_YET_RECRUITING
Università degli Studi Magna Graecia, Catanzaro
RECRUITING
Vi.Gi. Centro Polispecialistico, Vibo Valentia
RECRUITING
IRCCS San Raffaele Pisana, Roma
NOT_YET_RECRUITING
Ospedale Policlinico Agostino Gemelli, Roma
Ekalab S.r.l.
INDUSTRY